F-group (family)
182.1.1.1 FAD_binding_7
Ligands and drugs
275
Member domains
159
with ligand contacts (≤ 4 Å)
57.8% of members
133
with DrugDomain annotations
48.4% of members
105
with a DrugBank compound
38.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 182.1.1.1 belongs to X-group 182 Cryptochrome/photolyase FAD-binding domain-related, which binds 6.7 ligand superclasses per 20 proteins, narrower than 64% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 105 |
| DB12676 | MHF | Modufolin | 13 |
| DB00131 | AMP | Adenosine phosphate | 8 |
| DB02618 | NDS | Ethyl Dimethyl Ammonio Propane Sulfonate | 2 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB03247 | FMN | Flavin mononucleotide | 1 |
| DB03462 | TDR | Thymine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 129 |
| CL | CHLORIDE ION | 32 |
| MGmetal | MAGNESIUM ION | 14 |
| MHF | 5,10-METHENYL-6,7,8-TRIHYDROFOLIC ACID | 13 |
| AMP | ADENOSINE MONOPHOSPHATE | 8 |
| HDF | 8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE | 7 |
| DYX | 1-(4-chlorophenyl)-N-[2-(4-methoxyphenyl)-5,5-bis(oxidanylidene)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]cyclopentane-1-carboxamide | 5 |
| 2CX | N-[(2S)-3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(furan-2-ylmethyl)methanesulfonamide | 4 |
| H8X | N-[(2R)-3-carbazol-9-yl-2-oxidanyl-propyl]-N-(furan-2-ylmethyl)methanesulfonamide | 3 |
| ZNmetal | ZINC ION | 3 |
| 5YH | 1-[(2R)-3-[3,6-bis(fluoranyl)carbazol-9-yl]-2-oxidanyl-propyl]imidazolidin-2-one | 2 |
| DYU | ~{N}-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethyl-benzamide | 2 |
| EUL | 2-bromanyl-N-(5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)benzamide | 2 |
| FDA | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | 2 |
| FO1 | 1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol | 2 |
| GOC | N-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-4-(phenylcarbonyl)benzamide | 2 |
| NDS | ETHYL DIMETHYL AMMONIO PROPANE SULFONATE | 2 |
| 6I3 | 2-(1-methylbenzimidazol-2-yl)sulfanyl-N-[(E)-(2,3,4-trimethoxyphenyl)methylideneamino]ethanamide | 1 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 1 |
| DYR | 2-carbazol-9-yl-N-(2-chloranyl-6-cyano-phenyl)ethanamide | 1 |